Home  |  Contact

Cellosaurus LiPSC-GR1.2 (CVCL_RL66)

[Text version]
Cell line name LiPSC-GR1.2
Synonyms 50-001-02D
Accession CVCL_RL66
Resource Identification Initiative To cite this cell line use: LiPSC-GR1.2 (RRID:CVCL_RL66)
Comments From: Lonza, Inc.; Basel; Switzerland.
Population: Hispanic.
Omics: Array-based CGH.
Omics: Transcriptome analysis by microarray.
Derived from site: In situ; Umbilical cord blood; UBERON=UBERON_0012168.
HLA typing Source: PubMed=27283945
Class I
HLA-AA*02,03
HLA-BB*07,39
HLA-CC*07,15
Class II
HLA-DQDQB1*03,04
HLA-DRDRB1*04,08
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Originate from same individual CVCL_RL65 ! LiPSC-GR1.1
CVCL_RH35 ! ND50038
CVCL_RH36 ! ND50039
CVCL_UX45 ! NH50191
Sex of cell Male
Age at sampling <1D
Category Induced pluripotent stem cell
STR profile Source(s): PubMed=27283945

Markers:
AmelogeninX,Y
CSF1PO12
D3S135815
D5S81811
D7S82010,11
D8S117913,14
D13S3179,11
D16S53911,13
D18S5114
D21S1131.2,33.2
FGA18,25
Penta D11,13
Penta E7,11
TH016,9.3
TPOX8
vWA16

Run an STR similarity search on this cell line
Publications

PubMed=26411904; DOI=10.1016/j.stemcr.2015.08.015
Baghbaderani B.A., Tian X.-H., Neo B.H., Burkall A., DiMezzo T., Sierra G., Zeng X.-M., Warren K., Kovarcik D.P., Fellner T., Rao M.S.
cGMP-manufactured human induced pluripotent stem cells are available for pre-clinical and clinical applications.
Stem Cell Reports 5:647-659(2015)

PubMed=27283945; DOI=10.1007/s12015-016-9662-8
Baghbaderani B.A., Syama A., Sivapatham R., Pei Y., Mukherjee O., Fellner T., Zeng X.-M., Rao M.S.
Detailed characterization of human induced pluripotent stem cells manufactured for therapeutic applications.
Stem Cell Rev. Rep. 12:394-420(2016)

Cross-references
Encyclopedic resources Wikidata; Q54902576
Gene expression databases GEO; GSM1854270
Entry history
Entry creation05-Mar-2018
Last entry update29-Jun-2023
Version number7